Related references
Note: Only part of the references are listed.Probucol modulates oxidative stress and excitotoxicity in Huntington's disease models in vitro
Dirleise Colle et al.
BRAIN RESEARCH BULLETIN (2012)
Probucol, a lipid-lowering drug, prevents cognitive and hippocampal synaptic impairments induced by amyloid β peptide in mice
Danubia B. Santos et al.
EXPERIMENTAL NEUROLOGY (2012)
NEUROTOXIN-BASED MODELS OF PARKINSON'S DISEASE
J. Bove et al.
NEUROSCIENCE (2012)
Antioxidant protection: A promising therapeutic intervention in neurodegenerative disease
Nilanjan Ghosh et al.
FREE RADICAL RESEARCH (2011)
Central nervous system activity of the proanthocyanidin-rich fraction obtained from Croton celtidifolius in rats
Eduardo L. G. Moreira et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2010)
Missing pieces in the Parkinson's disease puzzle
Jose A. Obeso et al.
NATURE MEDICINE (2010)
Where are we with probucol: A new life for an old drug?
Shizuya Yamashita et al.
ATHEROSCLEROSIS (2009)
Glutathione-a review on its role and significance in Parkinson's disease
Heather L. Martin et al.
FASEB JOURNAL (2009)
Probucol Increases Glutathione Peroxidase-1 Activity and Displays Long-Lasting Protection against Methylmercury Toxicity in Cerebellar Granule Cells
Marcelo Farina et al.
TOXICOLOGICAL SCIENCES (2009)
Oxidative Stress in Parkinson's Disease A Mechanism of Pathogenic and Therapeutic Significance
Chun Zhou et al.
MITOCHONDRIA AND OXIDATIVE STRESS IN NEURODEGENERATIVE DISORDERS (2008)
Redox imbalance in Parkinson's disease
Shankar J. Chinta et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2008)
Long-Term Probucol Treatment Prevents Secondary Cardiovascular Events: a Cohort Study of Patients with Heterozygous Familial Hypercholesterolemia in Japan
Shizuya Yamashita et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2008)
Genetic deletion or antagonism of kinin B1 and B2 receptors improves cognitive deficits in mouse a model of Alzheimer's disease
R. D. S. Prediger et al.
NEUROSCIENCE (2008)
Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis
Claire Henchcliffe et al.
NATURE CLINICAL PRACTICE NEUROLOGY (2008)
Beneficial synergistic effects of concurrent treatment with cilostazol and probucol against focal cerebral ischemic injury in rats
So Youn Park et al.
BRAIN RESEARCH (2007)
Mitochondrial dysfunction in Parkinson's disease
Jiro Fukae et al.
MITOCHONDRION (2007)
Molecular basis of 6-hydroxydopamine-induced caspase activations due to increases in oxidative stress in the mouse striatum
Ken-ichi Tanaka et al.
NEUROSCIENCE LETTERS (2006)
A rapid and transient ROS generation by cadmium triggers apoptosis via caspase-dependent pathway in HepG2 cells and this is inhibited through N-acetylcysteine-mediated catalase upregulation
Seon-Hee Oh et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2006)
Oxidative and antioxidative potential of brain microglial cells
R Dringen
ANTIOXIDANTS & REDOX SIGNALING (2005)
Peroxide detoxification by brain cells
R Dringen et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2005)
Glutathione peroxidase-catalase cooperativity is required for resistance to hydrogen peroxide by mature rat oligodendrocytes
O Baud et al.
JOURNAL OF NEUROSCIENCE (2004)
Ebselen protects against methylmercury-induced inhibition of glutamate uptake by cortical slices from adult mice
M Farina et al.
TOXICOLOGY LETTERS (2003)
Peroxynitrite and mitochondrial dysfunction in the pathogenesis of Parkinson's disease
M Ebadi et al.
ANTIOXIDANTS & REDOX SIGNALING (2003)
Glutathione pathways in the brain
R Dringen et al.
BIOLOGICAL CHEMISTRY (2003)
The cholesterol-lowering drug probucol increases apolipoprotein E production in the hippocampus of aged rats: Implications for Alzheimer's disease
D Champagne et al.
NEUROSCIENCE (2003)
Oxidative stress in Parkinson's disease
P Jenner
ANNALS OF NEUROLOGY (2003)
Biochemical and Therapeutic Effects of Antioxidants in the Treatment of Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis
Vincenzo Di Matteo et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2003)
Pathogenesis of Parkinson's disease:: Dopamine, vesicles and α-synuclein
J Lotharius et al.
NATURE REVIEWS NEUROSCIENCE (2002)
Effects of coenzyme Q10 in early Parkinson disease -: Evidence of slowing of the functional decline
CW Shults et al.
ARCHIVES OF NEUROLOGY (2002)
Experimental models of Parkinson's disease
MF Beal
NATURE REVIEWS NEUROSCIENCE (2001)
Autoxidation and neurotoxicity of 6-hydroxydopamine in the presence of some antioxidants:: Potential implication in relation to the pathogenesis of Parkinson's disease
R Soto-Otero et al.
JOURNAL OF NEUROCHEMISTRY (2000)
Share Paper
